Search for: "CBE Group" Results 1 - 20 of 144
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Jun 2012, 2:00 am by slemberg
District Court, Northern District of Illinois, against CBE Group. [read post]
12 May 2020, 3:53 am by CMS
Most strikingly, the regime permits group claims to be brought on an “opt-out” basis, akin to a U.S. [read post]
4 Feb 2014, 9:00 pm by Laurent Teyssèdre
Le considérant (9) recommande également d'exclure de cette qualification les groupes d'entreprises dont le pouvoir économique excéderait celui d'une PME. [read post]
22 Mar 2021, 7:00 am by Howard Bashman
“Because the substance of this appeal is as frivolous as its form, we will affirm the District Court’s summary judgment and grant Appellee CBE Group’s motion for damages under Rule 38 of the Federal Rules of Appellate Procedure. [read post]
17 Jan 2023, 4:00 pm by Laurent Teyssèdre
Pour la Chambre, l'exigence de concision de l'article 84 CBE n'est donc pas respecté. [read post]
4 May 2020, 7:11 am by CMS
Most strikingly, the regime permits group claims to be brought on an “opt-out” basis, akin to a U.S. [read post]
7 Jan 2014, 9:00 pm by Laurent Teyssèdre
La requête n'est donc pas recevable.Au demandeur qui prétend qu'aucun article ou règle de la CBE n'interdit un tel changement d'objet à partir du moment où il a été recherché, la Chambre rétorque qu'au contraire les articles et règles, lus ensemble, conduisent clairement à l'interdire:- l'Art 82 CBE exige qu'une demande ne contienne qu'un groupe d'inventions unitaires- la R.137(2) CBE… [read post]
1 Nov 2006, 3:43 pm
The three firms currently under contract to peform these services are The CBE Group Inc., Linebarger Goggan Blair & Sampson, LLP, and Pioneer Credit Recovery, Inc. [read post]
17 Jan 2008, 7:55 am
Liggett Group, Inc., 505 U.S. 504 (1992) (holding that state common law torts were something that was subject to preemption), Medtronic, Inc. v. [read post]
20 Mar 2011, 10:00 pm
Cette combinaison avait été considérée comme contraire à l'Art 123(2) CBE par la division d'opposition. [read post]
8 Jan 2024, 9:42 am by Frank Cranmer
Quick links Full Fact: Can you hand back a CBE? [read post]
1 Sep 2011, 10:04 am by Laurent
La Grande Chambre fait remarquer au point 4.5.3 que l'on ne peut pas systématiquement affirmer, par une règle de logique, que si une demande divulgue un enseignement général et des modes de réalisation spécifiques, des groupes ou des domaines, alors elle divulgue inévitablement tous les autres modes de réalisation, groupes ou domaines potentiels tombant dans l'enseignement général mais non… [read post]
14 Aug 2018, 2:28 am by Roel van Woudenberg
      La règle 101(1) CBE prévoit notamment que si le recours n’est pas conforme aux articles 106-108 CBE, la Chambre de recoursle rejette comme irrecevable. [read post]
9 Sep 2009, 4:00 am
("CBE"), an executive network based in Arlington, VA. [read post]
1 Sep 2016, 10:54 am by Abbott & Kindermann
Bunger, quoted in Logan Noblin, “Environmental Groups Lose CEQA Appeal,” The Daily Recorder (July 21, 2016), p.2   [read post]
15 Dec 2020, 12:45 am by CMS
The most significant feature of the regime was the introduction of the option for group claims to be brought on an “opt-out” basis, akin to a U.S. [read post]
15 Sep 2011, 12:00 am by Joel Outten
Public Citizen, a consumer rights advocacy group, filed a petition last month asking the US Food and Drug Administration (FDA) to amend regulations that prevent generic drug manufacturers from updating product labels with pertinent safety data.According to the petition, manufacturers of generic drugs are not authorized to update their labels through the prior-approval-supplement (PAS) or changes being-effected (CBE) procedures available to the manufacturers of brand-name drugs.  [read post]
15 Sep 2011, 12:00 am by Joel Outten
Public Citizen, a consumer rights advocacy group, filed a petition last month asking the US Food and Drug Administration (FDA) to amend regulations that prevent generic drug manufacturers from updating product labels with pertinent safety data.According to the petition, manufacturers of generic drugs are not authorized to update their labels through the prior-approval-supplement (PAS) or changes being-effected (CBE) procedures available to the manufacturers of brand-name drugs. [read post]